Relative hypoglycemia of enteric coated oral insulin capsules containing polycarbophil without and with sodium salicylate or sodium cholate in diabetic rabbits

Saudi Pharmaceutical Journal

Volumn 7, Issue 1-2, 1999, Pages 28-33

  Hosny, Ehab A ^a  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

Author keywords

Diabetic rabbits; Oral insulin capsules; Polycarbophil; Sodium cholate; Sodium salicylate

Indexed keywords

ALLOXAN; CH 9470; CHOLIC ACID; INSULIN; POLYCARBOPHIL; SALICYLATE SODIUM; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DRUG ABSORPTION; DRUG COATING; DRUG FORMULATION; DRUG GRANULE; DRUG POTENTIATION; ENTERIC COATED TABLET; GLUCOSE BLOOD LEVEL; HYPOGLYCEMIA; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; RABBIT; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0032772239     PISSN: 13190164     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Paulsen EP, Courtney JW and Duckworth WC. Insulin resistance caused by massive degradation of subcutaneous insulin. Diabetes 1979; 28 : 640-645.
2. Freidenberg G, White N, Cataland S, O'Dorisio T, Sotos J and Santiago J. Diabetes responsive to intravenous but not subcutaneous insulun: Effectiveness of aprotinin. N Engl J Med 1980; 305: 363-368.
3. Maberly GF, Wait GA, Kilpatrick JA, Loten EG, Gain KR, Stewart RDH and Eastman CJ. Evidence for insulin degradation by muscle and fat tissues in an insulin resistant diabetic patient. Diabetologia 1982; 23 : 333-336.
4. Driver RL and Murlin JR. Factors in the absorption of insulin from alimentary tract. Am J Physiol 1940; 132 : 281-292.
5. Taniguchi K, Muranishi S and Sezaki H. Enhanced intestinal permeability of macromolecules. Part 2. Improvement of large intestinal absorption of heparin by lipid surfactant mixed micelles in rat. Int J Pharm 1980; 4 : 219-228.
6. Galloway JA and Toot MA. New forms of insulin. Diabetes 1972; 21: 637-648.
7. Touitou E and Rubinstein A. Targeted enteral delivery of insulin to rats. Int J Pharm 1986; 30 : 95-99.
8. Patel HM, Harding HGL, Logue F, Kesson CM, Mac Cuish AC, Mc Kenzie JF, Rynan BE and Scobie IN. Intrajejunal absorption of liposomally entapped insulin in normal man. Biochem Soc Transactions 1978; 6 : 784-785.
9. Arrieta-Molero JE, Aleck K, Sinha MK, Brownscheidle CM, Shapiro LJ and Sperling MA. Orally administered liposomesentrapped insulin in diabetic animals. A critical assesment. Horm Res1982; 16 : 249-256.
10. Das N, Basu MK and Das MK. Oral application of insulin encapsulated iposomes. Biochem Int 1989; 16 : 983-989.
11. Choudhari KB, Labhasetwar V and Dorle AK. Liposomes as carrier for oral administration of insulin: effect of formulation factors. J Microencapsul 1994; 11: 319-325.
12. Bird J, Best R and Lewis DA. The encapsulation of insulin in erythrocytes. J Pharm Pharmacol 1983; 35 : 246-247.
13. Shao Z, Li Y, Chermok T and Mitra AK.Cyclodextrin as mucosal absorption promoters of insulin II. Effects of beta-cyclodextrin derivatives on alpha-chymotrptic degradation and enterai absorption of insulin in rats. Pharm Res 1994; 11: 1174-1179.
14. Hosny EA, Khan Ghilzai NM and Al-Dhawalie AH. Effective intestinal absorption of insulin in diabetic rats using enteric coated capsules containing sodium salicylate. Drug Dev Ind Pharm 1995; 21: 1583-1589.
15. Hosny EA, Khan Ghilzai NM, and Elmazar MM. Promotion of oral insulin absorption in diabetic rabbits using pH-dependent coated capsules containing sodium cholate. Pharm Acta Helv 1997; 72 : 203-207.
16. Hosny EA, Khan Ghilzai NM, Al-Najar TA and . Elmazar MM. Hypoglycemic effect of oral insulin in diabetic rabbits using pH-dependent coated capsules containing sodium salicylate without and with sodium cholate. Drug Dev Ind Pharm 1998; 24 : 307-311.
17. Markus R.L. U.S. Patent 1965; 3, 202, 577.
18. Khosla R and Davis SS. Effect of polycarbophil on the gastric emptying of pellets. J Pharm Pharmacol 1987; 39 : 47-49.
19. Ito R, Machida Y, Sannan T and Nagai T. Magnetic granules:Novel system for specific drug delivery to esophageal mucosa in oral administration. Int J Pharm 1990; 61 : 109-117.
20. Lue Ben HL, Lehr CM, Rentel CO, Noach ABJ, de Boer AG, Verhoef JC and Junginer HE. Bioadhesive polymers for the peroral delivery of peptide drugs. J Control Rel 1994; 29 : 329-338.
21. Luessen HL, Verhoef JC, Borchard G, Lehr CM, de Boer AG and Junginger HE. Mucoadhesive polymers in peroral peptide drug delivery. II . Carbomer and polycarbophil are potent inhibitors of the intestinal enzyme trypsin. Pharm Res 1995; 12 :1293-1298.
22. Mikos AG and Peppas NA. Systems for controlled release of drugs. v. Bioadhesive systems. S T P Pharma 1986; 2 : 705-716.
23. Hosny EA. Relative hypoglycemia of rectal insulin suppositories containing deoxycholic acid, sodium taurocholate, polycarbophil and their combinations in diabetic rabbits. Drug Dev Ind Pharmacy (accepted).
24. Gordon GS, Moses AC, Silver RD, Flier JS and Carey M. Nasal absorption of insulin: Enhancement by hydrophobic bile salts. Proc Natl Acad Sci 1985; 82 : 7419-7423.
25. Dachateau GSMJE, Zuidema J. and Merkus FWHM. Bile salts and intranasal drug absorption. Int J Pharm 1986; 31 : 193-199.
26. Hirai S, Yashiki T and MimaL H. Mechanisms for the enhancement of the nasal absorption of insulin by surfactants. Int J Pharm 1981; 9 : 173-184.
27. Ziv EL and Kidron M. Absorption of protein via intestinal wall. A quantitative model. Biochem Pharmacol 1987; 36 : 1035-1039.